Identification of the Kna/Knb polymorphism and a method for Knops genotyping

Transfusion

Volumn 44, Issue 2, 2004, Pages 164-169

  Moulds, Joann M ^a   Thomas, B J ^b   Doumbo, O ^b   Diallo, D A ^b   Lyke, K E ^b   Plowe, C V ^b   Rowe, J A ^b   Birmingham, D J ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP KN ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR; DNA; KNOPS HELGESON ANTIGEN; MCC ANTIGEN; SL1 ANTIGEN; SL2 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP; DNA SEQUENCE; ERYTHROCYTE; ETHNIC GROUP; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALARIA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; AFRICAN AMERICAN; CAUCASIAN; ETHNOLOGY; GENETICS; INCIDENCE; MALI; NEGRO; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GROUP ANTIGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; INCIDENCE; MALARIA; MALI; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT 3B; UNITED STATES;

EID: 1242322082     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00615.x     Document Type: Article

References (18)

1. a), a high frequency erythrocyte antigen. Transfusion 1970;10: 137-8.
2. Molthan L. The serology of the York-Cost-McCoy-Knops red blood cell system. Am J Med Technol 1983;49:49-56.
3. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J Exp Med 1991;173:1159-63.
4. Rao N, Ferguson DJ, Lee SF, Telen MI. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3502-7.
5. Moulds JM, Moulds JJ, Brown M, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/ York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992;62:230-5.
6. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997;388:292-5.
7. Molthan L. The status of the McCoy/Knops antigens. Med Lab Sci 1983;40:59-63.
8. Moulds MK. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Technol 1981;47:789-95.
9. Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97(9):2879-85.
10. a. Transfusion 2002;42:251-6.
11. Daniels GL, Cartron JP, Fletcher A, et al. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver report. Vox Sang 2003;84:244-7.
12. Krych-Goldberg M, Hauhart RE, Subramanian VB. Decay accelerating activity of complement receptor type one (CD35): two active sites are required for dissociating C5 convertases. J Biol Chem 1999;274:31160-8.
13. Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517-20.
14. Moulds JM, Kassambara L, Middleton JL, et al. Identification of complement receptor one (CR1) polymorphisms in West Africa. Genes Immun 2000;1:325-9.
15. Tamasauskas D, Powell V, Schawalder A, Yazdanbakhsh K. Localization of Knops system antigens in the long homologous repeats of complement receptor 1. Transfusion 2001;41:1397-404.
16. a (Abstract). Transfusion 1980;20:630.
17. Zimmerman PA, Fitness J, Moulds JM, et al. CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun 2003;4:368-73.
18. Moulds JM, Brown LL. Loss of complement receptor one (CR1) from stored blood and its effect on Knops blood group reactivity. Immunohematology 1995;11:46-50.